DELLE FAVE, Gianfranco
 Distribuzione geografica
Continente #
NA - Nord America 16.151
EU - Europa 2.968
AS - Asia 2.021
SA - Sud America 116
AF - Africa 59
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.328
Nazione #
US - Stati Uniti d'America 15.983
SG - Singapore 802
IT - Italia 741
IN - India 715
UA - Ucraina 654
SE - Svezia 545
FI - Finlandia 454
CN - Cina 431
DE - Germania 152
CA - Canada 114
GB - Regno Unito 111
AR - Argentina 98
IE - Irlanda 77
BG - Bulgaria 45
TG - Togo 39
TT - Trinidad e Tobago 32
BE - Belgio 31
FR - Francia 30
RU - Federazione Russa 28
ID - Indonesia 26
MX - Messico 22
NL - Olanda 22
RO - Romania 21
IR - Iran 19
ES - Italia 15
CH - Svizzera 11
AU - Australia 8
LT - Lituania 8
ZA - Sudafrica 7
AT - Austria 6
CL - Cile 6
JP - Giappone 6
KR - Corea 6
BR - Brasile 5
PL - Polonia 5
SC - Seychelles 5
ZW - Zimbabwe 5
CO - Colombia 4
EU - Europa 4
EG - Egitto 3
PE - Perù 3
PK - Pakistan 3
SA - Arabia Saudita 3
CZ - Repubblica Ceca 2
GR - Grecia 2
PT - Portogallo 2
TH - Thailandia 2
TR - Turchia 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BY - Bielorussia 1
FJ - Figi 1
HK - Hong Kong 1
HR - Croazia 1
HU - Ungheria 1
LU - Lussemburgo 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TW - Taiwan 1
Totale 21.328
Città #
Fairfield 3.073
Woodbridge 1.462
Ashburn 1.250
Seattle 1.210
Houston 1.197
Cambridge 949
Wilmington 882
Chandler 841
Ann Arbor 628
Singapore 523
Princeton 409
San Paolo di Civitate 382
Plano 368
Lawrence 310
Boston 262
Jacksonville 259
Beijing 248
San Diego 212
Rome 209
Dearborn 198
Santa Clara 150
Millbury 106
Des Moines 93
Federal 91
Andover 87
Boardman 84
Helsinki 84
Norwalk 81
Dublin 77
Toronto 61
Sofia 45
Falls Church 40
Lomé 39
Ottawa 39
Falkenstein 37
Fremont 36
Hefei 32
Valsayn 32
Brussels 31
Jakarta 26
Nanjing 26
Bühl 25
Kunming 20
Mannheim 19
London 17
Los Angeles 17
New York 17
Bremen 14
Dallas 14
Phoenix 14
Redmond 14
San Mateo 12
Shanghai 12
Buffalo 11
Moscow 11
Indiana 10
Milan 10
Bern 9
Jinan 9
Yekaterinburg 9
Auburn Hills 8
Redwood City 8
Southend 8
Grafing 7
Guangzhou 7
Philadelphia 7
Shenyang 7
Frankfurt am Main 6
Mexico City 6
Paris 6
Harare 5
Kilburn 5
Laurel 5
Montréal 5
Nanchang 5
Nuremberg 5
Prescot 5
Provo 5
Springfield 5
Tappahannock 5
Washington 5
Winnipeg 5
Bogotá 4
Drohobych 4
Florence 4
Hebei 4
Hounslow 4
Lappeenranta 4
Madrid 4
Muizenberg 4
Romans-sur-isère 4
Sydney 4
São Paulo 4
Tokyo 4
Warsaw 4
Wenzhou 4
Acqui Terme 3
Chengdu 3
Guwahati 3
Jerez de los Caballeros 3
Totale 16.631
Nome #
Alteration of local microflora and α-defensins hyper-production in colonic adenoma mucosa 119
Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations. 113
CARD15 and Toll-like receptor 4 mutations in Italian patients with inflammatory bowel disease 111
"Mucosal healing" in ulcerative colitis: Between clinical evidence and market suggestion. 110
Epidemiology, clinical features and treatment of chronic pancreatitis. current knowledge and future perspectives [Epidemiologia, clinica e terapia medica della pancreatite cronica: evidenze attuali e sviluppi per il futuro] 108
Nasogastric or nasointestinal feeding in severe acute pancreatitis 107
Endocrine tumours of the stomach 107
Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate. 102
Risk Factors for Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas: A Multicentre Case-Control Study. 99
No higher risk for colorectal cancer in atrophic gastritis-related hypergastrinemia 98
Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway 98
Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms 95
HCV infection, B-cell non-Hodgkin's lymphoma and immunochemotherapy: Evidence and open questions. 94
Probiotics and severe acute pancreatitis 93
A pancreatico-pleural fistula diagnosed with magnetic resonance cholangiopancreatography 93
Celiac Disease and CFTR Mutations in Patients With Chronic Asymptomatic Pancreatic Hyperenzymemia 93
Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid. 92
Small intestinal bacterial overgrowth in patients with chronic pancreatitis. 92
The neutrophil/lymphocyte ratio at diagnosis is significantly associated with survival in metastatic pancreatic cancer patients 92
Abdominal tuberculosis with pancreatic involvement: a case report 92
TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study 92
Antral gastrin cell hyperfunction and Helicobacter pylori infection. 91
Endoscopic evaluation of the upper gastrointestinal tract is worthwhile in premenopausal women with iron-deficiency anaemia irrespective of menstrual flow. 91
Functional imaging in the follow-up of enteropancreatic neuroendocrine tumors. Clinical usefulness and indications 91
Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian association for the study of the pancreas. 90
ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms 90
Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms 88
Can patient characteristics predict the outcome of endoscopic evaluation of iron deficiency anemia: a multiple logistic regression analysis 88
BOMBESIN EFFECTS ON HUMAN GI FUNCTIONS 88
Gadoxetic acid-enhanced MRI for hepatocellular carcinoma and hypointense nodule observed in the hepatobiliary phase 87
Repeated transabdominal ultrasonography is a simple and accurate strategy to diagnose a biliary etiology of acute pancreatitis. 87
Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas 86
White paper of Italian Gastroenterology: delivery of services for digestive diseases in Italy: weaknesses and strengths. 85
Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: Foregut, midgut, hindgut, and unknown primary 85
ACUTE INFECTIOUS DIARRHEA. 84
Use and safety perception of herbal remedies in patients with liver/biliary tract disorders 84
Consequences of Helicobacter pylori infection on the absorption of micronutrients. 84
ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. 84
Role of the gut barrier in acute pancreatitis. 83
Gastric neuroendocrine tumors. 82
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence 81
Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas 81
Reversal of atrophic body gastritis after H. pylori eradication at long-term follow-up 81
Real-world study of everolimus in advanced progressive neuroendocrine tumors. 81
Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic) 81
Benefit of concomitant gastrointestinal and gynaecological evaluation in premenopausal women with iron deficiency anaemia 81
Oesophageal GIST. MDCT findings of two cases and review of the literature 81
Effect of somatostatin on gastrin, insulin and glucagon secretion in two patients with Zollinger-Ellison syndrome 80
Management of Neuroendocrine Tumors: A Meeting of Experts from Latin America 79
MODULATION OF CHOLECYSTOKININ ACTIVITY BY ALBUMIN 79
P27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior. 79
A case of oesophageal ulcer developed after taking homeopathic pill in a young woman 79
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization 78
CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis 78
Thyroxine in goiter, Helicobacter pylori infection and chronic gastritis 77
Patients with hematological malignancies and serological signs of prior resolved hepatitis B. 77
Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis 76
Malignant pancreatic neuroendocrine tumour: Lymph node ratio and Ki67 are predictors of recurrence after curative resections 76
Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. 76
Genetic susceptibility to pancreatic cancer and its functional characterisation: The PANcreatic Disease ReseArch (PANDoRA) consortium 76
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: Factors associated with response and suggestions for therapeutic sequence: Response to comments by Ezziddin et al. 76
A case of pheochromocytoma with renal artery stenosis and post-surgical watery diarrhea 76
Early onset pancreatic cancer. Risk factors, presentation and outcome 76
Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells 76
Efficacy of gluten-free diet alone on recovery from iron deficiency anemia in adult celiac patients 76
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study 75
Outcomes of intraductal papillary mucinous neoplasm with "Sendai-positive" criteria for resection undergoing non-operative management. 75
Corpus-predominant gastritis as a risk factor for false-negative 13C-urea breath test results. 75
Acute fulminant hepatitis E virus genotype 3e infection: Description of the first case in Europe. 75
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid. 75
Clinical relevance of the expression of somatostatin receptors in digestive endocrine tumours 75
Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. 75
Hepatitis B virus infection 74
Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patients 74
Reassessment of Intrinsic Factor and Parietal Cell Autoantibodies in Atrophic Gastritis With Respect to Cobalamin Deficiency 74
Gastrin and spaghetti: what is physiological? 74
Gastric and duodenal neuroendocrine tumours. 74
Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine Tumors 74
Coeliac disease and non-alcoholic fatty liver disease. 73
Src kinase activity coordinates cell adhesion and spreading with activation of mammalian target of rapamycin in pancreatic endocrine tumour cells 73
Alternative polyadenylation of ZEB1 promotes its translation during genotoxic stress in pancreatic cancer cells 73
Inhibitory effect of somatostatin on neutral amino acid transport in isolated brain microvessels. 73
Mucosal adhesion and anti-inflammatory effects of Lactobacillus rhamnosus GG in the human colonic mucosa. A proof-of-concept study 72
First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: When should it be done? 72
Effectiveness of octreotide in controlling fasting hypergastrinemia and related enterochromaffin-like cell growth 72
Co-existence of hyperparathyroidism, hypergastrinaemia and multiple gastric carcinoids is not always due to incomplete expression of the MEN-1 syndrome 71
Symptom-based approach to colorectal cancer: survey of primary care physicians in Italy. 71
Zollinger-Ellison syndrome and antral G-cell hyperfunction in patients with resistant duodenal ulcer disease 71
Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor 71
Intragastric ascorbic but not uric acid is depleted in relation with the increased pH in patients with atrophic body gastritis and H. pylori gastritis. 70
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients 70
Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients. 70
Development of an Ex Vivo Organ Culture Technique to Evaluate Probiotic Utilization in IBD 70
Gastric acid and pancreatic polypeptide responses to modified sham feeding: Indication of an increased basal vagal tone in a subgroup of duodenal ulcer patients 69
Molecular Pathogenesis of Neuroendocrine Tumors: Implications for Current and Future Therapeutic Approaches 69
Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors 68
Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger-Ellison syndrome and antral G-cell hyperfunction. 68
Pre-endoscopic screening for Helicobacter pylori and celiac disease in young anemic women 68
Molecular pathology and genetics of pancreatic endocrine tumours 68
Endoscopic snare papillectomy: A possible radical treatment for a subgroup of T1 ampullary adenocarcinomas 68
Totale 8.224
Categoria #
all - tutte 61.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.961


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.835 0 0 0 0 0 788 799 733 668 425 277 145
2020/20211.618 245 281 99 162 38 129 42 146 156 187 105 28
2021/20224.148 27 265 407 144 499 91 146 427 463 343 576 760
2022/20233.361 736 904 96 341 356 324 37 140 279 56 72 20
2023/20241.209 103 192 49 76 92 88 19 53 12 202 150 173
2024/2025907 153 85 212 118 188 151 0 0 0 0 0 0
Totale 21.722